Financials EPE Special Opportunities Limited
Equities
ESO
BMG3163K1053
Investment Management & Fund Operators
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
176.5 GBX | +0.57% | -0.84% | +9.63% |
04-02 | EARNINGS: EPE Special "cautiously optimistic"; RTW Biotech NAV rises | AN |
03-28 | Earnings Flash (ESO.L) EPE SPECIAL OPPORTUNITIES Reports FY24 Loss GBX-1.33 | MT |
Valuation
Fiscal Period: January | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Capitalization 1 | 42.8 | 65.41 | 87.12 | 97.41 | 50.43 | 49.3 |
Enterprise Value (EV) 1 | 17.59 | 43.74 | 63.23 | 93.42 | 52.91 | 47.27 |
P/E ratio | -6.54 x | 1.76 x | 2.32 x | 17.3 x | -1.2 x | -118 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 155 x | 1.65 x | 2.07 x | 9.47 x | -1.28 x | 13.1 x |
EV / Revenue | 63.6 x | 1.1 x | 1.5 x | 9.09 x | -1.34 x | 12.6 x |
EV / EBITDA | - | - | - | - | - | - |
EV / FCF | -10 x | 1.88 x | 2.61 x | 19 x | -2 x | 64.9 x |
FCF Yield | -9.99% | 53.3% | 38.4% | 5.27% | -50.1% | 1.54% |
Price to Book | 0.73 x | 0.63 x | 0.62 x | 0.68 x | 0.52 x | 0.51 x |
Nbr of stocks (in thousands) | 27,880 | 32,871 | 32,149 | 31,524 | 29,665 | 29,877 |
Reference price 2 | 1.535 | 1.990 | 2.710 | 3.090 | 1.700 | 1.650 |
Announcement Date | 19-04-09 | 20-04-16 | 21-03-24 | 22-03-22 | 23-03-21 | 24-03-28 |
Income Statement Evolution (Annual data)
Fiscal Period: January | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales 1 | 0.2763 | 39.67 | 42.02 | 10.28 | -39.36 | 3.751 |
EBITDA | - | - | - | - | - | - |
EBIT 1 | -2.256 | 36.55 | 38.57 | 6.203 | -42.4 | 0.7819 |
Operating Margin | -816.41% | 92.13% | 91.8% | 60.33% | 107.73% | 20.84% |
Earnings before Tax (EBT) 1 | -6.671 | 36.22 | 38.25 | 5.726 | -43.84 | -0.3965 |
Net income 1 | -6.671 | 36.22 | 38.25 | 5.726 | -43.84 | -0.3965 |
Net margin | -2,414.27% | 91.32% | 91.04% | 55.7% | 111.38% | -10.57% |
EPS 2 | -0.2347 | 1.129 | 1.167 | 0.1786 | -1.418 | -0.0139 |
Free Cash Flow 1 | -1.757 | 23.32 | 24.26 | 4.925 | -26.52 | 0.7289 |
FCF margin | -635.87% | 58.77% | 57.74% | 47.9% | 67.37% | 19.43% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | 64.36% | 63.42% | 86% | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 19-04-09 | 20-04-16 | 21-03-24 | 22-03-22 | 23-03-21 | 24-03-28 |
Balance Sheet Analysis
Fiscal Period: January | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | 2.48 | - |
Net Cash position 1 | 25.2 | 21.7 | 23.9 | 3.99 | - | 2.02 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -1.76 | 23.3 | 24.3 | 4.92 | -26.5 | 0.73 |
ROE (net income / shareholders' equity) | -10.6% | 44.2% | 31.2% | 4.03% | -36.4% | -0.41% |
ROA (Net income/ Total Assets) | -2.03% | 26.3% | 18.9% | 2.47% | -18.2% | 0.41% |
Assets 1 | 328.6 | 137.5 | 201.9 | 231.5 | 240.6 | -96.56 |
Book Value Per Share 2 | 2.100 | 3.170 | 4.380 | 4.560 | 3.280 | 3.240 |
Cash Flow per Share 2 | 1.020 | 0.7800 | 0.8700 | 0.8700 | 0.7500 | 0.4800 |
Capex | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 19-04-09 | 20-04-16 | 21-03-24 | 22-03-22 | 23-03-21 | 24-03-28 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+9.63% | 65.77M | |
+2.02% | 35.45B | |
+9.47% | 34.62B | |
+6.95% | 5.61B | |
-0.21% | 3.12B | |
+23.82% | 2.95B | |
+10.46% | 2.89B | |
-19.05% | 2.3B | |
+4.02% | 1.24B | |
+5.99% | 1.18B |
- Stock Market
- Equities
- ESO Stock
- Financials EPE Special Opportunities Limited